MOF/MODS, SIRS: An update

Shock

Volumn 6, Issue 6 SUPPL., 1996, Pages

  Baue, Arthur E ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; AGED; HUMAN; INFLAMMATION; INJURY; MIDDLE AGED; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; HUMANS; INFLAMMATION; MIDDLE AGED; MORBIDITY; MULTIPLE ORGAN FAILURE; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WOUNDS AND INJURIES;

EID: 0029684301     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199610001-00002     Document Type: Review

References (45)

1. Baue AE: Multiple, progressive or sequential systems failure. Arch Surg 110:779-781, 1975.
2. Baue AE: Organ dysfunction (MODS), organ failure (MOF) and therapeutic conundrums in injured and septic patients. In Gullo A (ed): Sepsis and Organ Failure, Vol. 2. Milano, Italy: Organ Failure Academy, Fogliazza Editore, 1994, pp 9-39.
3. Baue AE: Multiple organ failure (MOF), multiple organ dysfunction syndrome (MODS) and the systemic inflammatory response syndrome (SIRS): Where do we stand? Shock 2:385-397, 1994.
4. Eiseman B, Beart R, Norton L: Multiple organ failure. Surg Gynecol Obstet 144:323-326, 1977.
5. Fry DE (ed): Multiple Systems Organ Failure. St. Louis, MO: Mosby Year Book, 1992.
6. Border JR, Chemier R, McManamy RH, La Duca J, Seibel R, Birkhahn R, Yu L: Multiple systems organ failure: Muscle fuel deficit with visceral protein malnutrition. Surg, Clin North Am 56:1147-1167, 1976.
7. Deitch EA (ed): Multiple Organ Failure: Pathophysiology and Basic Concepts of Therapy. New York: Thieme Medical Publishers, Inc., 1990.
8. Marshall JC, Christou NV, Horn R, Meakins JL: The microbiology of multiple organ failure. Arch Surg 123:309-315, 1988.
9. Sauaia A, Moore FA, Moore EE, Haenel JB, Read RA, Lezotte DC: Early predictors of postinjury multiple organ failure. Arch Surg 129:39-45, 1994.
10. Tran DD, Cuesta MA, van Leeuwen PAM, Nauta JJP, Wesdorf RIC: Risk factors for multiple organ failure and death in critically injured patients. Surgery 114:21-30, 1993.
11. Baker CC, Miller ID, Baue AE: Predictors of outcome. J Trauma 23:627, 1983.
12. Faist E, Baue AE, Dittmer H, Heberer G: Multiple organ failure in polytrauma patients. J Trauma 17:389-393, 1983.
13. Meakins JL: Etiology of multiple organ failure. J Trauma 30:S165-168, 1990.
14. Moore FA, Sauaua A, Moore EE, Haenel JB, Burch JM, Lozotte DC: Postinjury multiple organ failure (MOF): A biomodal phenomenon. J Trauma 39:172, 1995.
15. Harken AH, Baneriee A: Traumatic stress can constructively precondition or destructively prime cells prior to a subsequent insult. Shock 3:24, 1995.
16. Baue AE: The horror autotoxicus and multiple organ failure. Arch Surg 127:1451-1462, 1992.
17. Nuytinck JKS, Goris JA, Redl H, et al: Posttraumatic complications and inflammatory mediators. Arch Surg 121:886-890, 1986.
18. Tanaka H, Sugimoto H, Yoshioa T, et al: Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple organ failure. Ann Surg 213:81-85, 1991.
19. Svoboda P, Katarová I, Ochmann J: Dynamics of interleukin 1, 2 and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma 36:336-340, 1994.
20. Fugger R, Zadrobilek E, Gotzinger P, et al: Perioperative TNF¶ and IL-6 concentrations correlate with septic state, organ fumction and APACHE III scores in intra-abdominal infection. Eur J Acta Chir 159:525-529, 1993.
21. Cerra FB, Maddaus MA, Dunn DL, Wells CL, Konstantinides NN, Lehmann SL, Mann HJ: Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit. Arch Surg 127:163-169, 1992.
22. Beale R, Bihar DJ: Multiple organ failure: The pilgrim's progress. Crit Care Med 21(suppl):S2-3, 1993.
23. Carrico CJ: The elusive pathophysiology of the multiple organ failure syndrome. Ann Surg 218:109-110.
24. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA: Sepsis syndrome, a valid clinical entity. Crit Care Med 17:389-393, 1989.
25. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM Consensus Conference on Sepsis and Organ Failure. Chest 101:1481-1483, 1992.
26. Baue AE: What's in a name? An acronym or a response? Am J Surg 165:299-301, 1993.
27. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ: The multiple organ dysfunction (MOD) score: A reliable descriptor of a complex clinical outcome. Crit Care Med. In press.
28. Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. JAMA 271:226-233.
29. Baue AE: Multiple organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome: Where do we stand? Shock 2:385-397, 1994.
30. Ziegler EJ, Fischer C, Sprung C, et al: The HA-1A Sepsis Study Group. Treatment of gram-negative bacteremia septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 324:429-436, 1991.
31. Greeman RL, Schein RMH, Martin MA, et al: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 266:1097-1102, 1991.
32. Fisher CJ, Slotman GJ, Opal SM, et al: Human recombinant interleukin-1 receptor antagonist (IL-1ra) in the treatment of patients with sepsis syndrome. Circ Shock 1:42, 1993.
33. Bone RC: Monoclonal antibodies to tumor necrosis factor in sepsis: Help or harm? Crit Care Med 21:311-312, 1993.
34. Dhainaut J-F A, Tenaillon A, LeTulzo Y: Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized double-blind, placebo-controlled, multicenter clinical trial. Crit Care Med 22:1720-1728, 1994.
35. Agosti JM, Fishr CJ, Opal SM, Lowry SF, Balk RA, Safodd JC: The sTNFR Sepsis Study Group: Treatment of patients with sepsis syndrome with soluble TNF receptor (sTNFR). Proceedings of the 34th Annual ICAAC. In press.
36. Stehbens WE: Causality in medical science with particular reference to heart disease and atherosclerosis. Perspect Biol 36:97-119, 1992.
37. Bone RC: Sepsis and controlled clinical trials: The odyssey. Crit Care Med 23:1165-1166, 1995.
38. Sibbald WJ, Vincent J-L: Round table conference on clinical trials for the treatment of sepsis. Crit Care Med 23:394-399, 1995.
39. Luiten EJT, Hop WCJ, Lange JF, Bruining HA: Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 222:57-65, 1995.
40. Lignau W, Berger J, Javorsky F, Benzer H: Selective gut decontamination in multple, trauma patients: A prospective, randomized trial. Shock 3 (suppl):17, 1995.
41. Cavaillon J-M, Marie C, Pitton C, Fitting C: Assessment of cell-associated cytokines following in vitro endotoxin stimulation, and in septic patients. Shock 3:33, 1995.
42. Poole GV, Hauser CJ, Lagoo S, Barber WH, Hardy KJ: Trauma upregulates human peripheral mononuclear cell expression of IL-10, not proinflammatory cytokines. Shock 3:5, 1995.
43. Echtenacher B, Falk W, Männel DN, Krammer PH: Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 145:3762-3766, 1990.
44. Popovsky MA, Moore SB: Diagnostic and pathogenic considerations in transfusion-related acute lung injury. Transfusion 25:573-577, 1985.
45. Durham RM, Neunaber K, Mazuski JE, Shapiro MJ, Baue AE: The use of oxygen consumption and delivery as endpoints for resuscitation in critically ill patients. J Trauma 39:172, 1995.